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INTRODUCTION
A number of epidemiologic studies have suggested that vita-
min D deficiency is associated with an increased incidence of 
asthma symptoms.
1-3 Vitamin D deficiency was thought to be 
eradicated with the fortification of foods and the apparent dis-
appearance of rickets. However, vitamin D deficiency has reap-
peared and is associated with many disorders.
4 Despite food 
fortification, multiple studies have shown that vitamin D defi-
ciency is highly prevalent even in sun-replete areas of the world
5 
and that vitamin D supplementation and fortification of foods 
in current doses are inadequate to prevent deficiency.
6
The existence of associations of vitamin D with asthma and 
allergy remains uncertain. While some suggest that vitamin D 
may be protective through prenatal or postnatal exposure, oth-
ers suggest that vitamin D supplementation may increase the 
risk of allergy.
7 Associations between serum vitamin D levels and 
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asthma severity in children and lung function in adults have 
been reported.
8,9 Higher maternal intake of vitamin D during 
pregnancy was associated with a decreased risk of recurrence 
of wheezing in young children.
7,10 Ginde et al.
11 found an in-
verse association between serum vitamin D levels and recent 
upper respiratory tract infections, especially in chronic respira-
tory diseases such as asthma. On the other hand, a case–con-
trol study on adults found that serum vitamin D levels did not 
differ between asthmatic patients and controls.
12
The present study examined the relationship of serum 25 hy-
droxy vitamin D3 levels with asthmatic state, pulmonary func-
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Purpose: Asthma and other allergic disorders have increased over the past decades in nearly all nations. Many studies have suggested the role of 
vitamin D deficiency in both T-helper1 and T-helper2 diseases; however, the association between vitamin D, allergy, and asthma remains uncertain. 
In this study, the associations of 25-hydroxy vitamin D3 levels with asthma and with the severity of asthma were evaluated.  Methods:  This cross-
sectional study was conducted on 50 asthmatic children and 50 healthy controls aged 6–18 years. Serum 25-hydroxy vitamin D3 levels were deter-
mined and compared between the two groups. The relationship between serum vitamin D levels and pulmonary function test outcomes and eosino-
phil counts were examined in asthmatic patients.  Results:  Univariate analysis of the relationship between asthma and vitamin D showed that de-
creased vitamin D levels were associated with significantly increased odds of asthmatic state (P=0.002). In a multivariate analysis after adjustment 
for age, body mass index, and sex, the relationship between vitamin D and asthma increased. In asthmatic patients, 25-hydroxy vitamin D levels had 
direct and significant correlations with both predicted FEV1 (R
2=0.318; P=0.024) and FEV1/FVC (R
2=0.315; P=0.026). There were no associations 
between vitamin D level and eosinophil counts, duration of disease, and the number of hospitalization or unscheduled visits in the previous year 
(P>0.05).  Conclusions:  These results showed that serum 25-hydroxy vitamin D levels were inversely associated with asthma, and there was a 
direct and significant relationship between vitamin D levels and pulmonary function test outcomes in asthmatic children. An interventional study in 
asthmatic patients with low serum vitamin D concentration may establish a causal relationship between asthma and vitamin D.
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tion measures, severity, and control of asthma.
 
MATERIALS AND METHODS
Study population
This cross-sectional study was carried out on 100 children aged 
6 to 18 years who had been referred to the Motahari Clinic of 
Shiraz University of Medical Sciences in autumn, 2009. The 
subjects included 50 asthmatic patients (31 males, 19 females; 
mean age 9.31 years), who were diagnosed based on the fol-
lowing criteria: 1) symptoms of recurrent (i.e., more than two) 
episodes of wheezing, cough, shortness of breath, or a combi-
nation of these; and 2) documented reversibility with broncho-
dilators.
13 Fifty healthy controls (31 males, 19 females; mean 
age 10.7 years) without a history of any allergic disorders in the 
child or first-degree relatives were also examined. The two 
groups were matched for age and sex (31 males, 19 females, 
aged 6–18 years).
Participants who had a history of consumption of any supple-
ments of vitamin D or drugs that modulate serum vitamin D 
levels, such as systemic glucocorticoids and anticonvulsants, 
and those who had chronic diseases were excluded.
A questionnaire completed through an interview included 
questions regarding age, sex, body mass index, and some out-
come measures related to asthma and its severity.
Serum 25(OH) vitamin D levels
Blood samples were collected during the examination and 
centrifuged, aliquoted, and frozen to -70°C until required. Se-
rum concentrations of 25(OH) D were assayed using an RIA kit 
(DRG, Marburg, Germany) after extraction with acetonitrile.
We compared serum vitamin D levels in the two groups (asth-
matic and healthy controls). Additionally, we examined the re-
lationship between vitamin D levels and the following outcomes: 
eosinophil count, baseline forced expiratory volume in 1 sec-
ond (FEV1), forced vital capacity (FVC), FEV1/FVC, use of anti-
inflammatory drugs in the previous year, any hospitalization or 
any unscheduled visits for asthma within the past year, and du-
ration and severity of disease.
In a descriptive analysis, we categorized vitamin D levels as 
deficient (<20 ng/mL), insufficient (≥20 and <30 ng/mL), or 
sufficient (≥30 ng/mL).
4,14
Peripheral blood eosinophil count
A peripheral smear was performed in asthmatic children, and 
after Wright staining, eosinophils were counted.
Pulmonary-function testing
In asthmatic subjects, spirometry was conducted with a spi-
rometer (Jaeger, flow screen, Würzburg, Germany). The best 
FEV1, FVC, and FEV1/FVC values were selected for analysis.
Statistical analysis
The data were statistically analyzed using Student’s t-test, one 
way ANOVA, and chi-square (linear by linear correlation) tests, 
as applicable (with a preset probability of P<0.05). Experimen-
tal results are presented as arithmetic mean±SD. Statistical 
tests were conducted using the SPSS software package, version 
16 (SPSS Inc., Chicago, IL, USA) on a personal computer. Addi-
tionally, using simple, multiple, and logistic regression analysis, 
the simultaneous effects of confounding variables such as, age, 
sex, vitamin D levels, and body mass index (BMI) on the asth-
matic state were measured. Normality assumptions of distribu-
tions were applicable based on the Kolmogorov–Smirnov test.
RESULTS
In this study, 100 children were examined (50 asthmatic and 
50 non asthmatic).
Table 1 shows the characteristics of both non-asthmatic and 
asthmatic subjects and the differences between the two groups. 
Mean 25(OH) D levels in the non-asthmatic and asthmatic 
groups were 66.82 and 49.29, respectively; this difference was 
statistically significant (Table 1; P=0.001).
The characteristics of asthmatic participants were stratified 
according to vitamin D quartiles. As shown in Table 2, in asth-
matic subjects, there were statistically significant differences 
between strata in terms of sex, BMI, and predicted FEV1 (P<
0.05). Female sex and lower predicted FEV1 were significant 
predictors of lower 25(OH) D levels. There were no other statis-
tically significant differences among the quartiles (P>0.05).
Categorization of vitamin D levels revealed no statistically sig-
nificant association between levels of vitamin D and asthmatic 
state (Table 3; linear by linear association=2.82; P=0.094).
Univariate analysis of the relationship between asthmatic state 
and age, sex, and vitamin D showed that younger age and low-
er vitamin D levels were associated with significantly increased 
odds of asthmatic state (P<0.05).
Multivariate analyses of the relationship between asthma and 
vitamin D levels with adjustment for age and sex were conduct-
ed. As shown in Table 4, after controlling for age and sex, a stron-
Table 1. Characteristics of patients in asthmatic and non-asthmatic groups
Parameter
Groups
P value
Non-asthma Asthma
Age (yr) 10.91±3.28 9.31±2.67 0.009*
Sex (female/male) 19/31 19/31 1
†
BMI (kg/m
2) 17.68±3.63 17.56±3.7 0.866*
Calcium 8.43±0.67 8.43±0.55 0.991*
Phosphorus 4.89±0.54 4.89±0.76 0.992*
Vitamin D 66.82±28.76 49.29±21.44 0.001*
*Two-sample t-test; 
†Chi-square test.
BMI, body mass index.The Relationship Between Vitamin D and Asthma
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ger relationship between vitamin D levels and asthmatic state 
can be seen compared with the univariate analysis. Thus, in-
creased vitamin D levels were associated with a greater decrease 
in the probability of asthmatic state compared with the univari-
ate analysis (odds ratio [OR]=0.95 and 0.97).
Linear association between vitamin D levels and lung-function 
parameters revealed that the associations between vitamin D 
level and predicted FEV1 (R
2=0.318; P=0.024) and FEV1/FVC 
(R
2=0.315; P=0.026) were statistically significant and those 
with baseline FEV1 and baseline and predicted FVC were not 
(P>0.05). The correlation between vitamin D levels and pre-
dicted FEV1 is shown in Figure.
Linear association analysis between vitamin D levels and eo-
sinophil counts and other outcomes (use of anti-inflammatory 
drugs in the previous year, any hospitalization or any unsched-
uled visits for asthma within the past year, and duration of dis-
ease) revealed no significant association (P>0.05).
DISCUSSION
Vitamin D is involved in the maintenance of immune homeo-
stasis. It has an important role in innate immunity; particularly 
Table 3. Vitamin D levels according to asthmatic state
Vitamin D levels
Asthmatic state
Asthma (%) Non-asthma (%)
<20 ng/mL 2 (4) 1 (2)
20–30 ng/mL 6 (12) 1 (2)
>30 ng/mL 42 (84) 48 (96)
Chi-square value for linear by linear association=2.82; P=0.094.
Table 4. Association between asthmatic state and age, sex, and Vitamin D lev-
els in multivariate analysis*
Parameter Coefficient of B Standard error OR (95% CI) P value
Age -0.321 0.092 0.726 (0.606–0.868) 0.0001
Sex
† 1.106 0.55 3.023 (1.029–8/88) 0.044
Vitamin D -0.05 0.013 0.951 (0.928–0.975) 0.0001
Constant 5/432 1.32 - 0.001
*BMI excluded from the model; 
†male is the reference group.
OR, odds ratio; CI, confidence interval.
Table 2. Characteristics of asthmatic patients
Characteristics
Asthmatic patients
(49.29±21.44 ng/mL)
Quartiles of vitamin D level
P value 1st quartile  
(16.4–33.23)
2nd quartile  
(33.24–43.25)
3rd quartile  
(43.26–61.28)
4th quartile  
(61.28 –102.9)
No. of patients 50 12 13 13 12
Age (yr) 9.31±2.67 10.21±3.34 9.69±2.31 7.92±1.55 9.5±2.94 0.156*
Sex (female/male) 19/31 7/5 6/7 6/7 0/12 0.006
†
BMI (kg/m
2) 17.56±3.7 15.85±4.55 20.02±2.9 16.03±2.74 18.26±3.01 0.008*
Eosinophil count (cells/mm
3) 236.3±136.4 217.83±176.61 238.08±134.98 254.46±115.15 233.08±128.54 0.932*
Use of anti-inflammatory drugs 
(no/yes)
17/33 4/8 4/9 4/9 5/7 0.687
†
Hospitalization in the previous 
year (no/yes)
42/8 11/1 11/2 10/3 10/2 0.487
†
Unscheduled visits (no/yes) 22/28 5/7 5/8 6/7 6/6 0.943
‡
FEV1, L (absolute) 1.92±0.71 2±0.99 1.91±0.57 1.7±0.56 2.1±128.54 0.552*
FEV1, L (predicted) 112.81±19.81 101.48±25.32 108.32±15.24 120.34±19.32 120.83±12.07 0.032*
FEV1/FVC ratio 100.08±18.33 93.72±16.89 93.22±24.65 106.85±14.87 106.53±10.43 0.084*
FVC, L (absolute) 2.23±1.07 2.66±1.64 2.15±0.79 1.95±0.93 2.2±0.73 0.415*
FVC, L (predicted) 105.15±29.83 105.43±45.48 102.41±25.02 109.48±30.76 103.14±12.08 0.936*
*One way ANOVA; 
†linear by linear correlation (chi-square); 
‡chi-square test.
BMI, body mass index; FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity.
Figure. Correlation between vitamin D levels and predicted FEV1.
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through the direct induction of antimicrobial peptide (catheli-
cidin) gene expression.
15,16 Vitamin D promotes the induction 
of T regulatory cells, including the expression of inhibitory cy-
tokines (IL-10 and TGFβ) and control of CD4-positive T lym-
phocytes (Th1 and Th2).
17,18 Vitamin D may reverse resistance 
to glucocorticoids in steroid resistant asthma
19 and potentiate 
the effect of allergen immunotherapy.
20 Observational studies 
suggest that vitamin D deficiency increases the risk of respira-
tory infection, which may contribute to the incidence of wheez-
ing illnesses in children and adults and cause asthma exacerba-
tions.
21 Polymorphisms in the gene encoding the vitamin D re-
ceptor have been associated with asthma phenotypes in two 
studies.
22,23 Additionally, some evidence has suggested the ef-
fects of vitamin D on lung growth and development in neo-
nates
24 and also on lung function in adults.
9 For the reasons not-
ed above, vitamin D may be related to asthma and its severity.
In this study, which was conducted based on the categoriza-
tion of vitamin D levels, 4% of asthmatic subjects had serum vi-
tamin D levels <20 ng/mL (compared with 2% in the control 
group), 12% had levels of 20–30 ng/mL (compared with 2% in 
the control group), and overall, 16% had levels ≤30 ng/mL 
(compared with 4% in the control group; P=0.094), which was 
not a statistically significant association. Brehm et al.
8 found 
that 25% of asthmatic patients had serum vitamin D levels <30 
ng/mL, and 3.4 % had levels <20 ng/mL. In this study, we com-
pared serum 25(OH) D levels in asthmatic subjects with those 
in a healthy control group. Although we observed higher preva-
lence of vitamin D insufficiency and deficiency in asthmatic 
children, this difference was not statistically significant. Howev-
er, in the univariate analysis, we found a strong inverse associa-
tion between serum vitamin D levels and asthmatic state. Also, 
in the multivariate analysis, after controlling for age and sex, this 
relationship had increased compared to the univariate analysis 
(OR=0.95–0.97). Thus, our data confirm the presence of lower 
vitamin D levels among asthmatic patients.
In our study, linear association analysis of serum 25(OH) D 
levels and measures of lung function revealed that the direct as-
sociations with predicted FEV1 (P=0.024) and also with FEV1/
FVC (P=0.026) were statistically significant. These findings sug-
gest the involvement of vitamin D in lung function and the de-
velopment of airflow limitation. However, the studies by Brehm 
et al.
8 and Litonjua et al.
25 reported contradictory data. Vitamin 
D inhibits the formation of matrix metalloproteinase as well as 
fibroblast proliferation and influences collagen synthesis; these 
actions mean that 1,25-dihydroxy vitamin D may influence tis-
sue remodeling and probably lung function.
26,27 Black and 
Scragg
9 found that serum 25-OH vitamin D level was positively 
associated with FEV1 and FVC in the United States’ general 
population.
Brehm et al.
8 found an inverse relationship between circulat-
ing levels of vitamin D and several markers of allergy and asth-
ma severity such as eosinophil count, IgE levels, asthma exac-
erbation, airway responsiveness, and skin-test reactivity. Liton-
jua et al.
25 found that children with insufficient levels of 25(OH) 
D were more likely to have severe exacerbations, but they did 
not find any association between vitamin D and bronchodila-
tor response or airway hyperresponsiveness. In our study, there 
were no associations between vitamin D levels and eosinophil 
counts, course of disease, asthma exacerbation, or anti-inflam-
matory drug use. This may be due to the smaller number of 
subjects and unequal sex distribution in both groups.
A number of confounding factors may influence these rela-
tionships. One is that the subjects with asthma spend more 
time indoors, so they may be exposed to less sunlight.
2 Howev-
er, we found a relationship between vitamin D and lung func-
tion outcomes that contribute to the severity of asthma, espe-
cially FEV1/FVC, which is a marker of airway obstruction. An-
other factor is the effects of other nutrients, such as vitamin E. 
Due to the strong evidence linking vitamin D deficiency to Th1 
diseases, the role of vitamin E is likely weaker.
2
Vitamin D deficiency is highly prevalent even in sun-replete 
areas of the world.
5 Some possible explanations include behav-
ioral factors (e.g. sunscreen use, increased time spent indoors, 
and clothing coverage) and intrinsic factors such as skin mela-
nin content, ethnicity (dark-skinned person), and decreased 
cutaneous production of vitamin D3.
28
Although there is no consensus regarding optimal 25-hydroxy 
vitamin D serum levels, based on epidemiologic studies, a de-
sirable level of serum vitamin D, i.e., 25(OH) D, for general 
health is at least 30 to 40 ng/mL (75 to 100 nmol/L).
4,6 It has been 
suggested that levels higher than 40 ng/mL (100 nmol/L) may 
be necessary for optimal immune functioning and overall 
health.
29 It seems that current national recommendations of vi-
tamin D (200–600 IU per day, depending on age) are insuffi-
cient to bring serum 25(OH) D levels to 75–100 nmol/mL, and, 
therefore, higher doses up to 700–1,000 IU per day may be nec-
essary.
30
In the present study, we found lower serum 25(OH) D levels 
in asthmatic children compared with controls, and we also 
found a direct relationship between serum 25(OH) D levels and 
lung-function measures. An interventional study in asthmatic 
patients with low serum vitamin D concentrations is now re-
quired to establish a causal relationship between asthma and 
vitamin D level.
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